Healthcare / Medical Care FacilitiesThailand
$3.92
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $104.0M · quality 49.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.1B
P/E
10.6x
↓EV/EBITDA
4.8x
↓ROE
9.7%
↑Gross Margin
28.4%
↓Debt/Equity
0.04
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+0.8%
FCF CAGR
—
FCF margin
-27.8%
FCF / Net income
-2.82x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.99B · net income $195.4M · FCF $-551.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.99B | $1.99B | $1.99B | $2.00B | $1.94B |
| Net Income | $195.4M | $195.4M | $233.7M | $282.3M | $320.9M |
| EBITDA | $394.0M | $394.0M | $428.5M | $491.1M | $505.7M |
| EPS | 0.37 | 0.37 | 0.58 | 0.53 | 0.60 |
| Gross Margin | 28.4% | 28.4% | 29.5% | 30.8% | 32.5% |
| Operating Margin | 13.0% | 13.0% | 15.0% | 17.9% | 20.6% |
| Net Margin | 9.8% | 9.8% | 11.8% | 14.1% | 16.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.04 | 0.04 | 0.12 | 0.05 | — |
| Current Ratio | 1.77 | 1.77 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-551.8M | $-551.8M | $104.0M | $206.6M | $209.7M |
| Returns | |||||
| ROE | 9.7% | 9.7% | 12.1% | 18.3% | 23.5% |
| Valuation | |||||
| P/E | 10.59 | 10.59 | — | — | — |
| EV/EBITDA | 4.78 | 4.78 | — | — | — |
| P/B | 1.04 | 1.04 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 0.0% | 0.0% | -0.9% | 3.4% | — |
| EPS Growth | -36.2% | -36.2% | 9.9% | -12.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-2.0%
EPS terminal req.
$0.35
Spread vs growth
-34.2%
5Y implied EPS CAGR
2.6%
EPS terminal req.
$0.42
Spread vs growth
-38.8%
10Y implied EPS CAGR
6.2%
EPS terminal req.
$0.68
Spread vs growth
-42.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.0%
Start / end P/E
6.8x → 10.6x
EPS bridge
0.58 → 0.37
Residual
-20.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.